Raising the voices in colon cancer screening

With proper screening, early detection of colorectal cancer often leads to a cure. Since the 1980s, incidents of colorectal cancer have declined—in fact, from 2011 to 2019, incidents dropped by about 1% each year. These promising statistics demonstrate the power of preventive screening.

Health coaching and nutrition: Quick tips for transforming your diet

What do great athletes, gifted musicians, actors and other elite performers have in common? They often rely on coaches behind the scenes. Coaches facilitate the learning and development of another. They give advice or instruction to improve performance and help a client reach the next level.

At-home FIT tests: How they help you detect colon cancer without getting a colonoscopy first

When it comes to colorectal cancer, there is one statistic—a promising one—that stands out: 90% of patients survive beyond 5 years when colon cancer is caught early. Early detection is the key to catching and treating colorectal cancer (CRC). The American Cancer Society recommends that everyone ages 45 to 75 get screened for CRC—further guidelines suggest that those age 75 and older should discuss with their primary care provider about whether or not they should be screened.

The routine screening that changed my life: Tee’s story

Rev. Dr. Timothy “Tee” Boddie knows the power of health screenings firsthand. This is the story of Tee, an ordained Baptist minister and well-respected member of his community, and the routine screening that saved his life.

Kidney health collection kit instructions

Mark Sausen, PhD

Dr. Mark Sausen has driven the planning, development and execution of projects in genetics and genomics for life sciences companies and academic research centers over the past 15 years.

 

Lab partnership reduces gaps in care and improves quality performance

A little more than 20 years ago, care delivery in California started to change. Large-scale independent physician associations (IPAs)—such as the subject of this case study—began taking on full-risk commercial contracts. These contracts, similar to more recent Medicare and ACO programs, were meant to improve patient care and reduce overall costs in a densely populated state. Since 2005, one large, California-based IPA has partnered with Labcorp to conduct yearly fecal occult blood test (FOBT) gap closure programs with a proven return track record of 30-40%. The success of this program is a result of the IPA care coordination team leveraging Labcorp’s data to identify patients with screening gaps and coordinate distribution of FIT testing home kits for patient collection. This made it easier for patients to fulfill screening, particularly in underserved populations.

Taylor Jensen, PhD

Dr. Taylor Jensen's role as Head of Oncology Science focuses on biomarkers, precision medicine assays, and product strategy in oncology.

 

Monitoring your heart health: How to help prevent cardiovascular disease

We all know that it’s important to keep your heart healthy—and 80% of cardiovascular disease, including heart disease and stroke, is preventable. Heart disease risk factors vary from person to person, so even if you’re otherwise healthy, you should consider screening for heart disease.

Sensitivity and concordance of CD274 expression by RNA sequencing (RNA-seq) in comparison with three PD-L1 immunohistochemistry methods in head and neck squamous cell carcinoma (HNSCC)